Member Info for Cwalsh

https://www.linkedin.com/posts/samuel-driscoll-a7453141_this-week-has-reconfirmed-to-me-how-important-activity-6732679536170864640-zjS6

It’s not fake , it’s from official Genedrive LinkedIn account .

Some positive read.

https://pharmafield.co.uk/opinion/implications-of-early-covid-19-vaccine-data/

Let me help you naming other one .. S****t T***z

Thank you dreamachine .

@Dreammachine, what’s your take on GDR’s non COVID projects ? Do you think this will go beyond 1£ If they have good projected income ? I am down nearly 50k on this and I am almost given up , i am not brave enough to sell and move on at the same time lost confidence on the company.

:-) , he is not given up yet.

Feck sake dude , hundreds of thousands at stake here and people worried about their investment and you want some cheap guessing games , go get some air man.

@joeline , you need to see your doctor first thing tomorrow morning.

@Invest , Divoc is not dealing with Genedrive anymore .

But all are on path to recover except Genedrive.

RIP Genedrive, down 50k , I am never gonna recover :-)

@dr, they should only if they have a contract for Significant amount or period , they don’t have to RNS if it is a normal trade.(as far as I know)

Not yet , keep an eye this page..

http://158.232.12.119/diagnostics_laboratory/EUL/en/

I am expecting end of November

Yes they have an approval to sell fish and chips in China, nothing to do with Covid.

@Technick, I am with you.

@Technick , the way I read is ‘50 mil tests been done using the components made by Cytiva ‘, like laboratory equipments , tools...

My only concern was lack of transparency, I will put those questions to DB .

@Dr, you need to take those with pinch of salt and move on , i am invested more than 100k and I am not worried and so some people here, I am Sure we will go home with decent profit.

Actual text from the article.

Cytiva has already been working with diagnostic developers during the COVID-19 pandemic. In total, over 50 million people have been PCR tested using components or services from Cytiva. Diagnostic components, such as nitrocellulose membranes, are used in 18 immunoassay-based COVID-19 tests available today. The new services will follow the same collaborative approach as Cytiva's work with Avacta. The companies are co-developing a rapid antigen test strip for COVID-19 to provide a result in minutes using patient saliva.